Interview with Jacek Barlinski, Country Manager, Nycomed Poland
As we are just starting 2011, could you share with us the results of Nycomed Poland in 2010? In 2010, the affiliate has not been as successful as the previous…
Address: Park LifeScience
ul. Bobrzyńskiego 14,
30-348 Kraków, Polska
Tel: +48 12 297 4605
Web: http://lifescience.pl/content.php?component=com_publisher§ion_id=1
The Krakow LifeScience Network is made up of like-minded companies and organisations in the Krakow area dedicated to bringing the best bio-business services and products to a global market. It is formed as The Project/Initiative.
Jagiellonian Centre of Innovation Ltd (the Partner in the initiative) manages the network in order to maintain its ongoing activities and quality service levels.
The management position has been appointed to secure realisation of stated goals, which include the following:
to be the single point of contact for ease of making relationships and exploring business and scientific collaborations,
to facilitate introductions to the network members from the global market,
get the network members ready to effectively engage wit the global lifescience market.
To create and sustain The Life Science Network to enable effective global connectivity and optimisation of existing pottential of individuals and organisations.
To support innovation and to encourage effective commercialization of results of research in the Life Science field.
To develop the resources and competences in the Life Science sector in order to effectively explore current existing and future opportunities related to development of a knowledge based economy.
As we are just starting 2011, could you share with us the results of Nycomed Poland in 2010? In 2010, the affiliate has not been as successful as the previous…
When we look at the full year 2010 unaudited IFRS consolidated sales, we see that Ipsen performed very well in 2010 in Central and Eastern Europe. How has Poland alone…
You joined Eli Lilly Poland in November 2008 as a Marketing Director and you have been leading the affiliate since January 2010. Moreover you are co-chairing the LAWG – Local…
The pharmaceutical industry market growth, including generics and originator drugs, is today steady and sustainable, approximating 10% year on year. The market size is over five billion Euros which makes…
In the pharma world, managers change frequently from one company to another, and this phenomenon has been accelerated with the consolidation of the market, however you chose to dedicate your…
Polski Holding Farmaceutyczny (PHF) was put together in 2004 as a capital group consisting of three leading Polish pharma producers and the mission given by the State Treasury Minister was…
For years Polpharma has been the market leader in Poland. In many countries the arrival of multinational companies (MNCs) led to the loss of leadership by the historical players to…
Unlike many pharmaceutical companies, Servier fully operates in all pharma business activities in Poland: research, drug manufacturing and distribution, and health education. Considering your extensive international and regional experience in…
With the current acquisition of Genzyme by Sanofi-Aventis, the French giant is planning to have Genzyme as a centre of excellence for rare diseases. Genzyme operates in the genetic market,…
Until very recently originator drugs had a very weak presence in central and east European countries including Poland, and there was no real patent legislation. Nevertheless, Poland has changed and…
The group has significantly invested in Poland. Are you today generally satisfied with the initial and follow up investments from Mediq in the country? The group has been present in…
Stretching across the heart of continental Europe, Poland is a massive bridge that links east and west, old and new, and which epitomizes a changing continent. At one time…
See our Cookie Privacy Policy Here